Goldman Sachs’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $33.1M | Buy |
1,820,391
+48,932
| +3% | +$891K | ﹤0.01% | 1406 |
|
2025
Q1 | $35.1M | Sell |
1,771,459
-927,227
| -34% | -$18.4M | 0.01% | 1280 |
|
2024
Q4 | $46.3M | Buy |
2,698,686
+87,009
| +3% | +$1.49M | 0.01% | 1139 |
|
2024
Q3 | $52.2M | Buy |
2,611,677
+1,578,574
| +153% | +$31.6M | 0.01% | 1032 |
|
2024
Q2 | $11.6M | Buy |
1,033,103
+129,031
| +14% | +$1.44M | ﹤0.01% | 1984 |
|
2024
Q1 | $5.97M | Sell |
904,072
-828,319
| -48% | -$5.47M | ﹤0.01% | 2434 |
|
2023
Q4 | $7.83M | Sell |
1,732,391
-515,229
| -23% | -$2.33M | ﹤0.01% | 2258 |
|
2023
Q3 | $8.05M | Buy |
2,247,620
+1,174,292
| +109% | +$4.2M | ﹤0.01% | 2138 |
|
2023
Q2 | $3.96M | Buy |
1,073,328
+120,951
| +13% | +$446K | ﹤0.01% | 2733 |
|
2023
Q1 | $3.15M | Buy |
952,377
+77,887
| +9% | +$258K | ﹤0.01% | 2892 |
|
2022
Q4 | $3.39M | Buy |
874,490
+254,280
| +41% | +$987K | ﹤0.01% | 2912 |
|
2022
Q3 | $1.51M | Buy |
620,210
+175,408
| +39% | +$426K | ﹤0.01% | 3556 |
|
2022
Q2 | $881K | Sell |
444,802
-225,420
| -34% | -$446K | ﹤0.01% | 4039 |
|
2022
Q1 | $1.23M | Buy |
670,222
+513,999
| +329% | +$940K | ﹤0.01% | 3960 |
|
2021
Q4 | $220K | Sell |
156,223
-82,122
| -34% | -$116K | ﹤0.01% | 4941 |
|
2021
Q3 | $270K | Buy |
238,345
+95,540
| +67% | +$108K | ﹤0.01% | 4720 |
|
2021
Q2 | $229K | Sell |
142,805
-232,591
| -62% | -$373K | ﹤0.01% | 4858 |
|
2021
Q1 | $661K | Buy |
375,396
+106,723
| +40% | +$188K | ﹤0.01% | 4178 |
|
2020
Q4 | $524K | Sell |
268,673
-327,452
| -55% | -$639K | ﹤0.01% | 3799 |
|
2020
Q3 | $1.42M | Buy |
596,125
+600
| +0.1% | +$1.43K | ﹤0.01% | 3094 |
|
2020
Q2 | $1.75M | Buy |
595,525
+101,351
| +21% | +$297K | ﹤0.01% | 2911 |
|
2020
Q1 | $1.42M | Buy |
494,174
+142,379
| +40% | +$410K | ﹤0.01% | 2932 |
|
2019
Q4 | $1.41M | Buy |
351,795
+225,126
| +178% | +$900K | ﹤0.01% | 3140 |
|
2019
Q3 | $564K | Buy |
126,669
+107,280
| +553% | +$478K | ﹤0.01% | 3539 |
|
2019
Q2 | $75K | Sell |
19,389
-1,955
| -9% | -$7.56K | ﹤0.01% | 4042 |
|
2019
Q1 | $81K | Buy |
+21,344
| New | +$81K | ﹤0.01% | 4033 |
|
2018
Q4 | – | Sell |
-32,807
| Closed | -$204K | – | 4062 |
|
2018
Q3 | $204K | Buy |
+32,807
| New | +$204K | ﹤0.01% | 3817 |
|
2018
Q2 | – | Sell |
-93,294
| Closed | -$429K | – | 4151 |
|
2018
Q1 | $429K | Buy |
93,294
+62,774
| +206% | +$289K | ﹤0.01% | 3553 |
|
2017
Q4 | $98K | Buy |
+30,520
| New | +$98K | ﹤0.01% | 3968 |
|
2016
Q1 | – | Sell |
-13,243
| Closed | -$107K | – | 4479 |
|
2015
Q4 | $107K | Sell |
13,243
-392
| -3% | -$3.17K | ﹤0.01% | 3966 |
|
2015
Q3 | $114K | Buy |
13,635
+698
| +5% | +$5.84K | ﹤0.01% | 4119 |
|
2015
Q2 | $120K | Sell |
12,937
-2,463
| -16% | -$22.8K | ﹤0.01% | 4250 |
|
2015
Q1 | $151K | Buy |
+15,400
| New | +$151K | ﹤0.01% | 4014 |
|